Projects per year
Abstract
Down-the-drain disposal of pharmaceuticals remains an overlooked and unrecognized source of environmental contamination that requires nontechnological “at-source” solutions. Monitoring of 31 pharmaceuticals over 7 days in five wastewater treatment plants (WWTPs) serving five cities in South-West UK revealed down-the-drain codisposal of six pharmaceuticals to three WWTPs (carbamazepine and propranolol in city A, sildenafil in city B, and diltiazem, capecitabine, and sertraline in city D), with a one-off record codisposal of estimated 253 pills = 40 g of carbamazepine and estimated 96 pills = 4 g of propranolol in city A accounting for their 10- and 3-fold respective increases in wastewater daily loads. Direct disposal of pharmaceuticals was found to affect the efficiency of wastewater treatment with much higher pharmaceutical removal (decrease in daily load) during “down-the-drain disposal” days. This is due to lack of conjugated glucuronide metabolites that are cleaved during “consumption-only” days, with the release of a parent pharmaceutical counterbalancing its removal. Higher removal of pharmaceuticals during down-the-drain disposal days reduced pharmaceutical loads reaching receiving environment, albeit with significant levels remaining. The estimated daily loads in receiving water downstream from a discharge point accounted for 13.8 ± 3.4 and 2.1 ± 0.2 g day-1of carbamazepine and propranolol, respectively, during consumption-only days and peaked at 20.9 g day-1(carbamazepine) and 4.6 g day-1(propranolol) during down-the-drain disposal days. Actions are needed to reduce down-the-drain disposal of pharmaceuticals. Our recent work indicated that down-the-drain disposal of pharmaceuticals doubled since the last study in 2005, which may be due to the lack of information and messaging that informs people to dispose of unused medicines at pharmacies. Media campaigns that inform the public of how to safely dispose of medicines are key to improving rates of return and reducing pharmaceutical waste in the environment. The environment is a key motivator for returning unused medicines to a pharmacy and so messaging should highlight environmental risks associated with improper disposal.
Original language | English |
---|---|
Pages (from-to) | 11657-11666 |
Number of pages | 10 |
Journal | Environmental Science & Technology |
Volume | 55 |
Issue number | 17 |
Early online date | 23 Aug 2021 |
DOIs | |
Publication status | Published - 7 Sept 2021 |
Bibliographical note
Funding Information:The support of Wessex Water Services Ltd. and EPSRC Impact Acceleration Account (Project nos.: EP/K503897/1 and EP/R51164X/1, ENTRUST IAA) is greatly appreciated. The support of the Leverhulme Trust (Project no. RPG-2013-297) is also greatly appreciated. All data supporting this study are provided as the supporting information accompanying this paper, as well as in Proctor et al. (SI).
Publisher Copyright:
© 2021 American Chemical Society
Keywords
- at-source wastewater treatment
- disposal
- pharmaceuticals
- wastewater-based epidemiology
- WBE
ASJC Scopus subject areas
- General Chemistry
- Environmental Chemistry
Fingerprint
Dive into the research topics of 'Diagnosing Down-the-Drain Disposal of Unused Pharmaceuticals at a River Catchment Level: Unrecognized Sources of Environmental Contamination That Require Nontechnological Solutions'. Together they form a unique fingerprint.-
The Somer Valley Innovative Pathway Control (IPC) project
Kasprzyk-Hordern, B. (PI), Kasprzyk-Hordern, B. (PI) & Jagadeesan, K. (Researcher)
9/11/20 → 3/02/25
Project: UK industry
-
IAA_Wessex Water - Wastewater Fingerprinting for Public Health Assessment (ENTRUST)
Kasprzyk-Hordern, B. (PI), Arnot, T. (CoI), Barnett, J. (CoI) & Standage, M. (CoI)
Engineering and Physical Sciences Research Council
1/09/17 → 31/03/20
Project: Research council
File